Roche to acquire TIB Molbiol Group to expand PCR-test portfolio against infectious diseases ruchika12 Sep 2021 4:30 AM GMTBasel: Roche has recently announced that the company has signed a definitive share purchase agreement to acquire 100% of the outstanding shares of the ...
Roche withdraws Tecentriq for treating type of breast cancer in US ruchika28 Aug 2021 4:30 AM GMTNew Delhi: Roche Holding AG has decided to withdraw its immunotherapy Tecentriq as a treatment for a type of breast cancer in the United States, the dr...
Roche gets USFDA nod for VENTANA MMR RxDx Panel ruchika19 Aug 2021 7:15 AM GMTBasel: Roche has recently announced that U.S. Food and Drug Administration (USFDA) has approved the VENTANA MMR RxDx Panel, the first companion di...
FIRST: Roche launches Spinal Muscular Atrophy treatment Evrysdi in India ruchika30 July 2021 8:00 AM GMTMumbai: Roche has announced the launch of Evrysdi (risdiplam), the first and only approved treatment in India for Spinal Muscular Atrophy (SMA) pa...
Japanese nod to Ronapreve (casirivimab and imdevimab) for treatment of mild to moderate Covid-19 ruchika20 July 2021 5:00 AM GMTBasel: Pharma major, Roche, today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve (casirivimab and imdevima...
Roche gets USFDA EUA for Actemra to treat Covid19 ruchika27 Jun 2021 4:30 AM GMTBasel: Roche has recently announced that the U.S. Food and Drug Administration (USFDA) has issued an Emergency Use Authorization (EUA) for intravenous ...
Roche Diabetes Care appoints Omar Sherief Mohammad as India, Middle East & Africa head ruchika2 Jun 2021 5:30 AM GMTNew Delhi: Roche has announced the appointment of Omar Sherief Mohammad as Head India, Middle East & Africa (IMEA) within the Roche Diabetes C...
First: Roche- CIPLA Antibody Cocktail of Casirivimab and Imdevimab for mild to moderate COVID-19 now available in India ruchika24 May 2021 9:14 AM GMTThe antibody cocktail (Casirivimab and Imdevimab) is to be administered for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in...
Roche Tecentriq Pivotal Phase III data shows hope for cancer patients ruchika20 May 2021 5:30 AM GMTBasel: Roche today announced interim results from the Phase III IMpower010 study, showing for the first time that treatment with Tecentriq (atezolizuma...
Roche India gets CDSCO nod to COVID antibody cocktail of Casirivimab, Imdevimab ruchika6 May 2021 8:30 AM GMTThe drug will be available through leading hospitals and COVID treatment centres, Roche India said.
Roche to acquire GenMark Diagnostics for USD 1.8 billion ruchika16 March 2021 7:48 AM GMTBasel: Roche and GenMark Diagnostics have recently announced that they have entered into a definitive merger agreement for Roche to fully acquire ...
Roche obtains CE mark for SARS-CoV-2 Rapid Antigen Test Nasal ruchika2 Feb 2021 9:00 AM GMTBesides being less invasive, the test also provides patients with the option to self-collect their nasal sample under the supervision of a healthcare...
